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Background: Dietary intake of nitrates, nitrites, and nitrosamines can increase the endogenous formation of
N-nitroso compounds in the stomach. Results from animal studies suggest that these compounds might be
teratogenic. We examined the relationship between maternal dietary intake of nitrates, nitrites (including plant and
animal sources as separate groups), and nitrosamines and several types of birth defects in offspring.
Methods: For this population-based case–control study, data from a 58-question food frequency questionnaire,
adapted from the short Willett Food Frequency Questionnaire and administered as part of the National Birth
Defects Prevention Study (NBDPS), were used to estimate daily intake of dietary nitrates, nitrites, and nitrosamines
in a sample of 6544 mothers of infants with neural tube defects (NTD)s, oral clefts (OC)s, or limb deficiencies (LD)s
and 6807 mothers of unaffected control infants. Total daily intake of these compounds was divided into quartiles
based on the control mother distributions. Odds ratios (OR)s and 95% confidence intervals (CI)s were estimated
using logistic regression; estimates were adjusted for maternal daily caloric intake, maternal race-ethnicity,
education, dietary folate intake, high fat diet (> 30% of calories from fat), and state of residence.
Results: While some unadjusted ORs for NTDS had 95% (CI)s that excluded the null value, none remained
significant after adjustment for covariates, and the effect sizes were small (adjusted odds ratios [aOR] <1.12). Similar
results were found for OCs and LDs with the exception of animal nitrites and cleft lip with/without cleft palate
(aORs and CIs for quartile 4 compared to quartile 1 =1.24; CI=1.05-1.48), animal nitrites and cleft lip (4th quartile
aOR=1.32; CI=1.01-1.72), and total nitrite and intercalary LD (4th quartile aOR=4.70; CI=1.23-17.93).
Conclusions: Overall, odds of NTDs, OCs or LDs did not appear to be significantly associated with estimated dietary
intake of nitrate, nitrite, and nitrosamines.
Keywords: Congenital malformation, Diet, Nitrate, Nitrite, Nitrosamine, PregnancyBackground
Findings from a few epidemiologic studies have suggested
that prenatal exposure to nitrates (from drinking water) [1]
and nitrites, especially in conjunction with nitrosatable
drugs [2,3], are associated with neural tube defects (NTD)s.
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reproduction in any medium, provided the oringestion [4]. This nitrite along with dietary nitrite can react
with amines and amides in an acidic environment such as
that found in the stomach to form nitrosamines and
nitrosamides [5]. Results from several animal studies have
indicated that various N-nitroso compounds may be terato-
genic [6-11]. In hamsters, nitrosamines have been noted to
cross the placental barrier [12], even at low doses [13].
In our previous studies of maternal nitrosatable drug
exposure among study participants in the National Birth
Defects Prevention Study (NBDPS), we found that 24%
of the control women (mothers who gave birth to babiestd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Selected maternal characteristics of birth defect cases and controls in the National Birth Defects Prevention
Study, 1997-2005
Characteristics of participants Control Neural tube defects Limb deficiencies Oral cleft defects
N = 6698 N = 1170 N = 693 N = 2727
N % N % N % N %
Race-ethnicitya,b,c
Non-Hispanic White 3,989 59.6 596 50.9 388 56.0 1,708 62.6
Non-Hispanic Black 758 11.3 108 9.2 71 10.3 173 6.3
Hispanic 1,464 21.9 377 32.2 190 27.4 640 23.5
Asian/Pacific Islander 197 2.9 25 2.1 14 2.0 81 3.0
Native American/Alaskan 29 0.4 7 0.6 3 0.4 23 0.8
Other 233 3.5 53 4.5 27 3.9 94 3.5
Missing 28 0.4 4 0.3 0 0.0 8 0.3
Maternal Education (years) a,c
<9 years 325 4.9 95 8.1 33 4.8 158 5.8
9-11 years 770 11.5 149 12.7 81 11.7 350 12.8
12 years 1,627 24.3 332 28.4 185 26.7 761 27.9
13-15 years 1,784 26.6 328 28.0 197 28.4 724 26.6
16 years or more 2,096 31.3 252 21.5 188 27.1 708 26.0
Missing 96 1.4 14 1.2 9 1.3 26 1.0
Age at Delivery (years) a,c
<18 years old 246 3.7 43 3.7 30 4.3 88 3.2
18-19 years old 465 6.9 94 8.0 53 7.7 190 7.0
20-24 years old 1,517 22.7 256 21.9 175 25.3 694 25.5
25-29 years old 1,781 26.6 381 32.6 172 24.8 728 26.7
30-34 years old 1,741 26.0 244 20.9 179 25.8 615 22.6
35-39 years old 810 12.1 111 9.5 73 10.5 342 12.5
40-44 years old 126 1.9 38 3.3 11 1.6 64 2.4
45-49 years old 11 0.2 3 0.3 0 0.0 6 0.2
>49 Years old 1 0.0 0 0.0 0 0.0 0 0.0
Study Centera,b,c
Arkansas 836 12.5 145 12.4 66 9.5 306 11.2
California 839 12.5 232 19.8 114 16.5 437 16.0
Georgia 749 11.2 138 11.8 73 10.5 302 11.1
Iowa 849 12.7 73 6.2 89 12.8 382 14.0
Massachusetts 568 8.5 68 5.8 78 11.3 189 6.9
North Carolina 596 8.9 70 6.0 49 7.1 246 9.0
New Jersey 772 11.5 162 13.9 92 13.3 343 12.6
New York 720 10.8 138 11.8 73 10.5 328 12.0
Texas 405 6.1 70 6.0 13 1.9 99 3.6
Utah 364 5.4 74 6.3 46 6.6 95 3.5
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Table 1 Selected maternal characteristics of birth defect cases and controls in the National Birth Defects Prevention
Study, 1997-2005 (Continued)
Maternal Body Mass Indexa,c (kg/m2)
Underweight (BMI <18) 353 5.3 48 4.1 38 5.5 183 6.7
Normal weight (18.5 -25) 3,585 53.5 544 46.5 337 48.6 1,376 50.5
Overweight (25–30) 1,443 21.5 243 20.8 164 23.7 569 20.9
Obese (≥30) 1,037 15.5 259 22.1 121 17.5 479 17.6
Missing 280 4.2 76 6.5 33 4.8 120 4.4
Folic Acid Supplement Usec
No 3,053 45.6 552 47.2 305 44.0 1,330 48.8
Yes 3,480 52.0 577 49.3 366 52.8 1,340 49.1
Missing 165 2.5 41 3.5 22 3.2 57 2.1
a Statistically significant difference in covariate distribution between control mothers and mothers of offspring with a NTD.
b Statistically significant difference in covariate distribution between control mothers and mothers of offspring with a limb malformation.
c Statistically significant difference in covariate distribution between control mothers and mothers of offspring with an orofacial cleft.
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more nitrosatable drugs during the first trimester [14].
These drugs have secondary amines, tertiary amines, or
amides as part of their molecular structures. In the NBDPS
study population, maternal exposures to nitrosatable drugs
were associated with neural tube defects [3], limb deficien-
cies [15], and some types of heart defects [15]. We noted
the strongest associations between maternal exposure to
these drugs and neural tube defects, conotruncal heartTable 2 Descriptive statistics of dietary nitrate, nitrite, and ni
Outcome N Mean (SD)
Nitrate (mg/day)
Anencephaly 319 48.02 (32.99)
Spina bifida 658 49.83 (43.40)
Encephalocele 127 49.75 (36.88)
Total Nitrite (mg/day)
Anencephaly 319 1.88 (0.99)
Spina bifida 662 1.85 (1.05)
Encephalocele 127 1.84 (1.04)
Animal Nitrite (mg/day)
Anencephaly 320 1.15 (0.70)
Spina bifida 673 1.14 (0.79)
Encephalocele 128 1.20 (0.89)
Plant Nitrite (mg/day)
Anencephaly 319 0.74 (0.51)
Spina bifida 666 0.72 (0.49)
Encephalocele 129 0.66 (0.37)
Nitrosamine (μg/day)
Anencephaly 315 0.53 (0.30)
Spina bifida 664 0.55 (0.34)
Encephalocele 127 0.52 (0.32)defects, atrioventricular septal defects, single ventricle, and
cleft palate in offspring of women with the highest esti-
mated total nitrite intake.
Studies investigating the relation between maternal
dietary exposures to nitrates, nitrites and nitrosamines
and birth defects have involved relatively small sample
sizes and were restricted to NTDs [1,2]. Furthermore,
these studies grouped plant and animal sources of nitrite
together. However, some plant sources of nitrites, suchtrosamine intake and neural tube defects in offspring
N (%)
Quartile 1 Quartile 2 Quartile 3 Quartile 4
90 (28.2) 84 (26.3) 65 (20.4) 80 (25.1)
179 (27.2) 168 (25.5) 172 (26.1) 139 (21.1)
35 (27.6) 28 (22.0) 37 (29.1) 27 (21.3)
74 (23.2) 63 (19.7) 86 (27.0) 96 (30.1)
157 (23.7) 153 (23.1) 165 (24.9) 187 (28.2)
32 (25.2) 31 (24.4) 28 (22.0) 36 (28.3)
71 (22.2) 71 (22.2) 89 (27.8) 89 (27.8)
157 (23.3) 166 (24.7) 180 (26.7) 170 (25.3)
37 (28.9) 23 (18.0) 31 (24.2) 37 (28.9)
76 (23.8) 84 (26.3) 65 (20.4) 94 (29.5)
170 (25.5) 162 (24.3) 138 (20.7) 196 (29.4)
29 (22.5) 31 (24.0) 38 (29.5) 31 (24.0)
77 (24.4) 77 (24.4) 84 (26.7) 77 (24.4)
181 (27.3) 150 (22.6) 157 (23.6) 176 (26.5)
34 (26.8) 34 (26.8) 26 (20.5) 33 (26.0)
Table 3 Maternal dietary intake of nitrate, nitrite, and nitrosamines and neural tube defects in offspring
Unadjusted odds ratios (95% CI) Adjusted odds ratios* (95% CI)
Outcome Quartile 1 vs
Quartile 2
Quartile 1 vs
Quartile 3
Quartile 1 vs
Quartile 4
Quartile 1 vs
Quartile 2
Quartile 1 vs
Quartile 3
Quartile 1 vs
Quartile 4
Nitrate
anencephaly 0.93 (0.68-1.27) 0.72 (0.52-1.01) 0.90 (0.66-1.23) 0.97 (0.71-1.34) 0.81 (0.56-1.17) 0.99 (0.67-1.45)
spina bifida 0.93 (0.74-1.16) 0.96 (0.77-1.20) 0.77 (0.61-0.97) 0.93 (0.73-1.17) 0.98 (0.77-1.26) 0.78 (0.59-1.04)
encephalocele 0.80 (0.48-1.32) 1.00 (0.62-1.60) 0.74 (0.45-1.24) 0.75 (0.45-1.26) 0.87 (0.52-1.48) 0.59 (0.32-1.08)
Total Nitrite
anencephaly 0.83 (0.59-1.18) 1.11 (0.80-1.54) 1.31 (0.96-1.79) 0.82 (0.57-1.18) 1.04 (0.73-1.49) 1.06 (0.69-1.64)
spina bifida 0.96 (0.76-1.22) 1.08 (0.86-1.36) 1.18 (0.94-1.48) 0.96 (0.76-1.23) 1.02 (0.79-1.32) 1.00 (0.73-1.38)
encephalocele 1.00 (0.60-1.66) 0.95 (0.56-1.59) 1.20 (0.74-1.97) 0.97 (0.57-1.64) 0.83 (0.47-1.47) 0.96 (0.49-1.89)
Animal Nitrite
anencephaly 1.01 (0.72-1.43) 1.27 (0.92-1.76) 1.27 (0.91-1.75) 1.00 (0.71-1.42) 1.22 (0.86-1.73) 1.12 (0.76-1.67)
spina bifida 1.07 (0.85-1.34) 1.16 (0.92-1.46) 1.07 (0.85-1.35) 1.06 (0.83-1.34) 1.12 (0.88-1.43) 1.00 (0.75-1.33)
encephalocele 0.59 (0.34-1.02) 0.88 (0.54-1.43) 1.04 (0.66-1.66) 0.59 (0.34-1.03) 0.86 (0.51-1.44) 0.98 (0.55-1.74)
Plant Nitrite
anencephaly 1.13 (0.81-1.56) 0.87 (0.62-1.23) 1.26 (0.92-1.73) 1.18 (0.84-1.66) 0.86 (0.59-1.26) 0.95 (0.60-1.50)
spina bifida 0.95 (0.75-1.19) 0.82 (0.65-1.05) 1.14 (0.92-1.43) 0.94 (0.74-1.20) 0.81 (0.62-1.05) 0.90 (0.65-1.24)
encephalocele 1.02 (0.61-1.71) 1.23 (0.75-2.02) 1.05 (0.63-1.76) 0.99 (0.58-1.70) 1.04 (0.59-1.82) 0.61 (0.30-1.25)
Nitrosamine
anencephaly 1.01 (0.73-1.40) 1.10 (0.80-1.52) 1.03 (0.74-1.43) 1.10 (0.78-1.55) 1.18 (0.82-1.68) 1.06 (0.70-1.60)
spina bifida 0.81 (0.65-1.03) 0.87 (0.69-1.09) 0.98 (0.78-1.22) 0.82 (0.64-1.04) 0.85 (0.66-1.10) 0.91 (0.69-1.21)
encephalocele 0.98 (0.60-1.60) 0.79 (0.47-1.33) 1.03 (0.63-1.68) 1.01 (0.60-1.68) 0.82 (0.47-1.46) 1.13 (0.60-2.11)
* Logistic regression models adjusted for energy intake, maternal race/ethnicity, dietary folate intake, folic acid supplementation, and dietary fat intake.
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C, while animal sources of nitrites are less likely to con-
tribute significantly to vitamin C intake. Vitamin C is a
well-documented inhibitor of nitrosation and the forma-
tion of N-nitroso compounds in the stomach [16]. This
study examines the relationship between maternal ex-
posure to dietary nitrates, nitrites (including plant and
animal sources as separate groups), and nitrosamines
and several types of birth defects including NTDs,
orofacial clefts, and limb malformations in a large,
population-based case–control study.
Methods
Study design and sample
We used data from the National Birth Defects Prevention
Study (NBDPS) [17] to address the study objectives.
Funded by the Centers for Disease Control and Preven-
tion, the NBDPS is a population-based, case–control study
that includes sites in Georgia, Arkansas, California, Iowa,
Massachusetts, New Jersey, New York, North Carolina,
Texas and Utah. Mothers who gave birth to babies with-
out congenital malformations (controls, n=6807) were
compared with case mothers (n=6544) whose pregnancies
were affected by orofacial clefts, limb deficiencies or
neural tube defects. Eligible participants had estimateddelivery dates from October 1, 1997 through December
31, 2005. Participants were excluded if their self-reported
daily caloric intake was below 500 calories or greater than
5000 calories. The demographic characteristics of the
mothers are described in Table 1.
Outcomes
This study focused on three major classes of birth de-
fects: neural tube defects, orofacial clefts and limb
malformations. Specific neural tube defects included an-
encephaly, spina bifida and encephalocele. Orofacial
clefts included cleft lip without cleft palate, cleft lip with
cleft palate, cleft palate, and cleft lip with or without
cleft palate. Limb malformations included longitudinal
limb deficiency, longitudinal preaxial limb deficiency (a
subcategory of longitudinal limb deficiency), transverse
limb deficiency, and intercalary limb deficiency. Cases
were identified through one of ten birth defect registries.
Most of the registry sites include prenatal diagnosis and
terminations (including Arkansas, California, Georgia,
Iowa, North Carolina, Texas, and Utah) to avoid the po-
tential for selection bias due to possible differences
between mothers who choose to terminate their preg-
nancies and those who do not. At each site, cases were
checked for validity by a clinician who reviewed the
Table 4 Descriptive statistics of dietary nitrate, nitrite, and nitrosamine intake and oral cleft defects in offspring
N (%)
Outcome N Mean (SD) Quartile 1 Quartile 2 Quartile 3 Quartile 4
Nitrate (mg/day)
Cleft lip only 613 50.31 (52.16) 165 (26.9) 162 (26.4) 139 (22.7) 147 (24.0)
Cleft lip with cleft palate 1133 48.65 (37.08) 293 (25.9) 309 (27.3) 273 (24.1) 258 (22.8)
Cleft palate only 910 49.86 (36.66) 230 (25.3) 233 (25.6) 224 (24.6) 223 (24.5)
Cleft lip with or without cleft palate 1746 49.23 (42.97) 458 (26.2) 471 (27.0) 412 (23.6) 405 (23.2)
Nitrite (mg/day)
Cleft lip only 614 1.75 (0.97) 166 (27.0) 136 (22.1) 158 (25.7) 154 (25.1)
Cleft lip with cleft palate 1133 1.88 (1.06) 263 (23.2) 262 (23.1) 275 (24.3) 333 (29.4)
Cleft palate only 910 1.72 (0.96) 257 (28.2) 211 (23.2) 228 (25.1) 214 (23.5)
Cleft lip with or without cleft palate 1747 1.83 (1.03) 429 (24.6) 398 (22.8) 433 (24.8) 487 (27.9)
Animal Nitrite (mg/day)
Cleft lip only 615 1.11 (0.75) 151 (24.6) 149 (24.2) 144 (23.4) 171 (27.8)
Cleft lip with cleft palate 1140 1.17 (0.78) 262 (23.0) 275 (24.1) 269 (23.6) 334 (29.3)
Cleft palate only 918 1.07 (0.71) 249 (27.1) 219 (23.9) 230 (25.1) 220 (24.0)
Cleft lip with or without cleft palate 1755 1.15 (0.77) 413 (23.5) 424 (24.2) 413 (23.5) 505 (28.8)
Plant Nitrite (mg/day)
Cleft lip only 614 0.64 (0.38) 153 (24.9) 160 (26.1) 162 (26.4) 139 (22.6)
Cleft lip with cleft palate 1140 0.71 (0.49) 280 (24.6) 274 (24.0) 261 (22.9) 325 (28.5)
Cleft palate only 914 0.65 (0.41) 242 (26.5) 221 (24.2) 251 (27.5) 200 (21.9)
Cleft lip with or without cleft palate 1754 0.69 (0.45) 433 (24.7) 434 (24.7) 423 (24.1) 464 (26.5)
Nitrosamine (μg/day)
Cleft lip only 614 0.72 (4.60) 169 (27.5) 126 (20.5) 171 (27.9) 148 (24.1)
Cleft lip with cleft palate 1133 0.53 (0.31) 302 (26.7) 269 (23.7) 283 (25.0) 279 (24.6)
Cleft palate only 908 0.52 (0.30) 264 (29.1) 226 (24.9) 209 (23.0) 209 (23.0)
Cleft lip with or without cleft palate 1747 0.60 (2.74) 471 (27.0) 395 (22.6) 454 (26.0) 427 (24.4)
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Cases from all sites were further classified by a clinical
geneticist before study analyses began. The institutional
review boards (for the protection of human subjects) at
each site and the Centers for Disease Control and Preven-
tion approved the NBDPS study protocol, and the institu-
tional review boards of Texas A&M University and the
Texas Department of State Health Services also approved
this project on maternal dietary intake of nitrates, nitrites,
and nitrosamines and birth defects.
Dietary intake of nitrate, nitrite, and nitrosamines
The exposures of interest included dietary nitrate (mg/day),
nitrite (mg/day) and nitrosamines (μg/day). Daily consump-
tion of nitrates, nitrites and nitrosamines was estimated
using a 58-item food frequency questionnaire based on the
Willett Food Frequency Questionnaire [19,20]. The NDBPS
questionnaire included additional region-specific fooditems such as avocados, raw chili peppers, salsa, tortillas,
cantaloupe, and refried beans that are commonly con-
sumed in this population.
The nitrate, nitrite and nitrosamine content of each
food item was estimated based on an extensive literature
review reported by Griesenbeck et al. [21]. Total daily
consumption of each compound was calculated by
multiplying the number of servings of each food item
eaten each day by the estimated content of nitrate, ni-
trite, and nitrosamines in the standard serving size and
summing over all food items. Due to the endogenous
conversion of nitrate to nitrite in the saliva and stomach,
5% of total dietary nitrate consumption was added to es-
timate total dietary nitrite consumption. Quartiles of ni-
trate, nitrite from animal and plant sources separately,
total nitrite, and nitrosamine intake were based on the
distributions of control mothers’ daily consumption of
these compounds, with the lowest quartile of each com-
pound used as the referent category in all analyses.
Table 5 Maternal dietary intake of nitrate, nitrite, and nitrosamines and oral cleft defects in offspring
Unadjusted odds ratios (95% CI) Adjusted odds ratios* (95% CI)
Outcome Quartile 1 vs
Quartile 2
Quartile 1 vs
Quartile 3
Quartile 1 vs
Quartile 4
Quartile 1 vs
Quartile 2
Quartile 1 vs
Quartile 3
Quartile 1 vs
Quartile 4
Nitrate
Cleft lip only 1.00 (0.80-1.26) 0.85 (0.67-1.08) 0.90 (0.71-1.14) 1.01 (0.80-1.28) 0.89 (0.68-1.15) 1.01 (0.76-1.33)
Cleft lip with cleft plate 1.05 (0.88-1.25) 0.93 (0.77-1.11) 0.89 (0.74-1.07) 1.07 (0.89-1.28) 0.96 (0.79-1.16) 0.90 (0.73-1.13)
Cleft palate only 1.02 (0.83-1.24) 0.99 (0.81-1.20) 0.98 (0.81-1.20) 1.06 (0.86-1.29) 1.05 (0.85-1.30) 1.15 (0.91-1.46)
Cleft lip with or without cleft palate 1.04 (0.89-1.20) 0.90 (0.77-1.05) 0.89 (0.77-1.04) 1.04 (0.90-1.22) 0.93 (0.79-1.09) 0.93 (0.78-1.12)
Nitrite
Cleft lip only 0.82 (0.64-1.04) 0.94 (0.75-1.19) 0.92 (0.73-1.17) 0.85 (0.67-1.08) 1.03 (0.80-1.33) 1.11 (0.81-1.51)
Cleft lip with cleft plate 0.99 (0.82-1.19) 1.04 (0.86-1.25) 1.25 (1.04-1.49) 1.02 (0.85-1.24) 1.02 (0.84-1.25) 1.12 (0.88-1.42)
Cleft palate only 0.82 (0.67-0.99) 0.87 (0.72-1.06) 0.83 (0.69-1.01) 0.85 (0.70-1.04) 0.97 (0.79-1.20) 1.02 (0.78-1.32)
Cleft lip with or without cleft palate 0.92 (0.79-1.08) 1.00 (0.86-1.16) 1.12 (0.97-1.30) 0.95 (0.81-1.11) 1.02 (0.86-1.20) 1.10 (0.91-1.35)
Animal Nitrite
Cleft lip only 0.98 (0.77-1.24) 0.92 (0.72-1.17) 1.12 (0.89-1.42) 1.00 (0.78-1.27) 1.00 (0.78-1.29) 1.32 (1.01-1.72)
Cleft lip with cleft plate 1.03 (0.86-1.24) 1.01 (0.84-1.21) 1.24 (1.04-1.48) 1.06 (0.88-1.28) 1.03 (0.85-1.24) 1.22 (0.99-1.49)
Cleft palate only 0.86 (0.71-1.05) 0.90 (0.74-1.10) 0.87 (0.72-1.06) 0.89 (0.73-1.08) 0.97 (0.79-1.19) 1.01 (0.80-1.27)
Cleft lip with or without cleft palate 1.01 (0.87-1.18) 0.97 (0.84-1.14) 1.20 (1.04-1.39) 1.03 (0.88-1.21) 1.01 (0.86-1.19) 1.24 (1.05-1.48)
Plant Nitrite
Cleft lip only 1.02 (0.81-1.29) 1.05 (0.83-1.32) 0.91 (0.71-1.15) 1.09 (0.85-1.39) 1.15 (0.89-1.50) 1.04 (0.74-1.46)
Cleft lip with cleft plate 0.98 (0.82-1.17) 0.92 (0.77-1.11) 1.16 (0.98-1.39) 1.03 (0.85-1.24) 0.95 (0.77-1.16) 0.98 (0.76-1.27)
Cleft palate only 0.92 (0.75-1.12) 1.03 (0.85-1.24) 0.84 (0.69-1.03) 0.97 (0.79-1.19) 1.15 (0.93-1.43) 1.01 (0.76-1.33)
Cleft lip with or without cleft palate 1.00 (0.86-1.16) 0.97 (0.83-1.12) 1.07 (0.92-1.24) 1.05 (0.89-1.23) 1.02 (0.86-1.20) 1.00 (0.81-1.24)
Nitrosamine
Cleft lip only 0.74 (0.58-0.94) 0.72 (0.56-0.92) 1.02 (0.81-1.27) 0.87 (0.69-1.09) 0.99 (0.78-1.26) 0.85 (0.64-1.13)
Cleft lip with cleft plate 0.89 (0.74-1.06) 0.89 (0.74-1.06) 0.93 (0.78-1.11) 0.90 (0.75-1.08) 0.95 (0.78-1.15) 0.89 (0.71-1.10)
Cleft palate only 0.85 (0.70-1.03) 0.86 (0.71-1.05) 0.77 (0.64-0.94) 0.78 (0.64-0.95) 0.85 (0.69-1.05) 0.88 (0.69-1.11)
Cleft lip with or without cleft palate 0.83 (0.72-0.97) 0.83 (0.71-0.96) 0.96 (0.83-1.11) 0.89 (0.76-1.03) 0.96 (0.82-1.13) 0.87 (0.73-1.04)
*Logistic regression models adjusted for energy intake, maternal race/ethnicity, maternal education, dietary folate intake, and study center.
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Data from dietary recall questionnaires often includes
some degree of measurement error. Since this study did
not include a “gold standard” for comparison purposes,
the effects of measurement error were evaluated using
the Simulation Extrapolation (SIMEX) algorithm [22]
and hypothetically varying the amount of measurement
error included in the model from no error to a multi-
plicative factor of 1.6 (60% additional variability) in
increments of 0.10. No substantive differences were
identified in terms of statistical significance or magni-
tude of effect size; therefore, all subsequent statistical
models were conducted using logistic regression with
maximum likelihood estimation as implemented in Stata
11 [23] and SAS 9.2 [24] to estimate the odds ratios and
respective 95% confidence limits for the specific defects.
Each specific type of birth defect was compared with
controls only, and pregnancies with other kinds of de-
fects were not included as controls.Covariates and model selection
Several demographic, dietary, and behavioral characteris-
tics including race/ethnicity, state of residence, dietary
folate (μg/day), maternal education (years in school), diet-
ary fat (percent of calories from fat), maternal household
income, pre-pregnancy body mass index (BMI) (kg/m2),
use of folic acid-containing supplements, multivitamin
use, and age at conception were found in a previous study
to be associated with dietary intake of nitrates, nitrites and
nitrosamines in the control group mothers [25]. These
variables were examined for potential confounding effects
using a backward selection procedure where covariates
were retained if their removal changed any of the three ex-
posure quartile parameters by more than 10%. In the
interest of interpretability, covariates were retained within
the broad classes of birth defects (i.e. NTD, orofacial de-
fect and limb malformation) if evidence of potential
confounding was identified in any of the constituent birth
defect sub-categories.
Table 6 Descriptive statistics of dietary nitrate, nitrite, and nitrosamine intake and limb deficiency defects in offspring
N (%)
Limb deficiency defect N Mean (SD) Quartile 1 Quartile 2 Quartile 3 Quartile 4
Nitrate (mg/day)
Longitudinal 245 47.12 (31.52) 73 (29.8) 55 (22.4) 60 (24.5) 57 (23.3)
Transverse 379 46.97 (33.93) 101 (26.6) 105 (27.7) 95 (25.1) 78 (20.6)
Intercalary 34 45.84 (24.04) 10 (29.4) 7 (20.6) 7 (20.6) 10 (29.4)
Preaxial* 143 45.19 (30.13) 46 (32.2) 32 (22.4) 34 (23.8) 31 (21.7)
Nitrite (mg/day)
Longitudinal 245 1.76 (0.96) 73 (29.8) 50 (20.4) 54 (22.0) 68 (27.8)
Transverse 379 1.80 (1.00) 95 (25.1) 102 (26.9) 86 (22.7) 96 (25.3)
Intercalary 34 1.86 (0.88) 5 (14.7) 9 (26.5) 7 (20.6) 13 (38.2)
Preaxial* 143 1.78 (1.02) 42 (29.4) 33 (23.1) 31 (21.7) 37 (25.9)
Animal Nitrite (mg/day)
Longitudinal 247 1.12 (0.79) 66 (26.7) 59 (23.9) 64 (25.9) 58 (23.5)
Transverse 381 1.12 (0.77) 99 (26.0) 94 (24.7) 90 (23.6) 98 (25.7)
Intercalary 34 1.26 (0.82) 5 (14.7) 7 (20.6) 9 (26.5) 13 (38.2)
Preaxial* 145 1.15 (0.87) 38 (26.2) 37 (25.5) 36 (24.8) 34 (23.4)
Plant Nitrite (mg/day)
Longitudinal 247 0.64 (0.36) 64 (25.9) 63 (25.5) 56 (22.7) 64 (25.9)
Transverse 381 0.68 (0.42) 101 (26.5) 89 (23.4) 83 (21.8) 108 (28.3)
Intercalary 34 0.60 (0.29) 8 (23.5) 9 (26.5) 10 (29.4) 7 (20.6)
Preaxial* 145 0.63 (0.34) 37 (25.5) 39 (26.9) 33 (22.8) 36 (24.8)
Nitrosamine (μg/day)
Longitudinal 245 0.56 (0.46) 65 (26.5) 62 (25.3) 55 (22.4) 63 (25.7)
Transverse 380 0.82 (5.82) 100 (26.3) 99 (26.1) 91 (23.9) 90 (23.7)
Intercalary 34 0.63 (0.30) 4 (11.8) 9 (26.5) 11 (32.4) 10 (29.4)
Preaxial* 143 0.52 (0.31) 41 (28.7) 34 (23.8) 33 (23.1) 35 (24.5)
* Subcategory of longitudinal limb deficiency.
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Table 1 displays the demographic characteristics of the
control group as well as each of the broad classes of
birth defects. A majority of the participants were of non-
Hispanic white race/ethnicity with the second most
common group being of Hispanic origin. The mothers
were relatively well educated with the majority having a
high school and/or college degree. Roughly half of all
mothers delivered their children between the ages of 20
and 29 and nearly three quarters delivered between the
ages of 20 and 34. Approximately half of all case and
control mothers had a body mass index (BMI) in the
normal range while nearly one third had a BMI in the
overweight and obese range. Roughly half of all case and
control mothers reported using folic acid supplements
during the first month of pregnancy.
Statistical significance in Table 1 is based on the pair-
wise comparison of each birth defect class case mothers
with the control mothers. The distributions of race/ethni-
city, maternal education, age at delivery, study center, andmaternal BMI for mothers of offspring with NTDs were
significantly different than the distributions of the control
mothers. The distributions of race/ethnicity and study
center for mothers of offspring with limb malformations
were significantly different than the distributions of the
control mothers. The distributions of race/ethnicity, ma-
ternal education, age at delivery, study center, maternal
BMI and folic acid use for mothers of offspring with oral
clefts were significantly different than the distributions of
the control mothers.
The descriptive statistics for daily consumption of
nitrates, total nitrites, animal nitrites, plant nitrites and
nitrosamines are shown in Table 2 for mothers of children
with NTDs. The results of the unadjusted and adjusted
logistic regression models for NTDs are shown in Table 3.
Compared to the first quartile of nitrate consumption, a
significant relationship was identified for the fourth quar-
tile for spina bifida (uOR = 0.77, 95% confidence interval =
0.61-0.97), but this association was not statistically signifi-
cant after adjustment for covariates.
Table 7 Maternal dietary intake of nitrate, nitrite, and nitrosamines and limb deficiency defects in offspring
Unadjusted odds ratios (95% CI) Adjusted odds ratios** (95% CI)
Limb deficiency defect Quartile 1 vs
Quartile 2
Quartile 1 vs
Quartile 3
Quartile 1 vs
Quartile 4
Quartile 1 vs
Quartile 2
Quartile 1 vs
Quartile 3
Quartile 1 vs
Quartile 4
Nitrate
Longitudinal 0.75 (0.52-1.07) 0.79 (0.55-1.13) 0.78 (0.55-1.11) 0.74 (0.51-1.06) 0.82 (0.56-1.19) 0.79 (0.52-1.20)
Transverse 1.07 (0.80-1.43) 0.97 (0.72-1.30) 0.80 (0.59-1.09) 1.02 (0.76-1.36) 0.91 (0.66-1.24) 0.73 (0.51-1.04)
Intercalary 0.70 (0.27-1.84) 0.70 (0.27-1.84) 1.00 (0.42-2.41) 0.76 (0.28-2.06) 0.90 (0.31-2.60) 1.40 (0.48-4.10)
Preaxial* 0.69 (0.43-1.10) 0.71 (0.45-1.12) 0.69 (0.43-1.10) 0.67 (0.42-1.07) 0.72 (0.44-1.18) 0.65 (0.37-1.13)
Nitrite
Longitudinal 0.67 (0.46-0.98) 0.77 (0.53-1.10) 0.93 (0.66-1.31) 0.69 (0.48-1.01) 0.75 (0.51-1.12) 0.95 (0.59-1.52)
Transverse 1.08 (0.81-1.45) 0.94 (0.70-1.28) 1.04 (0.77-1.39) 1.10 (0.82-1.48) 0.91 (0.65-1.27) 0.95 (0.63-1.42)
Intercalary 1.79 (0.60-5.36) 1.41 (0.45-4.46) 2.61 (0.93-7.33) 2.29 (0.74-7.07) 1.92 (0.56-6.59) 4.70 (1.23-17.93)
Preaxial* 0.80 (0.50-1.28) 0.78 (0.49-1.26) 0.90 (0.57-1.42) 0.74 (0.46-1.20) 0.65 (0.39-1.09) 0.64 (0.34-1.20)
Animal Nitrite
Longitudinal 0.87 (0.60-1.25) 0.99 (0.69-1.41) 0.89 (0.62-1.28) 0.91 (0.63-1.31) 0.95 (0.65-1.38) 0.83 (0.53-1.29)
Transverse 0.91 (0.67-1.22) 0.93 (0.69-1.25) 0.99 (0.74-1.33) 1.01 (0.75-1.37) 0.98 (0.72-1.34) 1.13 (0.79-1.61)
Intercalary 1.41 (0.45-4.47) 1.84 (0.61-5.49) 2.63 (0.94-7.41) 1.56 (0.48-5.01) 1.94 (0.61-6.15) 2.73 (0.80-9.37)
Preaxial* 0.96 (0.60-1.53) 0.97 (0.60-1.54) 0.93 (0.58-1.49) 0.96 (0.60-1.53) 0.84 (0.51-1.38) 0.69 (0.39-1.23)
Plant Nitrite
Longitudinal 0.96 (0.67-1.37) 0.87 (0.60-1.26) 0.97 (0.68-1.39) 1.00 (0.69-1.44) 0.91 (0.60-1.38) 1.06 (0.64-1.74)
Transverse 0.87 (0.64-1.17) 0.81 (0.60-1.10) 1.08 (0.81-1.43) 0.88 (0.65-1.20) 0.82 (0.58-1.14) 0.92 (0.61-1.38)
Intercalary 1.11 (0.43-2.89) 1.25 (0.49-3.16) 0.87 (0.31-2.39) 1.36 (0.50-3.70) 1.81 (0.62-5.28) 1.61 (0.40-6.47)
Preaxial* 1.05 (0.66-1.66) 0.89 (0.55-1.43) 0.96 (0.60-1.54) 1.09 (0.67-1.75) 0.91 (0.53-1.55) 0.90 (0.47-1.73)
Nitrosamine
Longitudinal 0.95 (0.67-1.37) 0.88 (0.61-1.27) 1.01 (0.71-1.45) 0.99 (0.68-1.42) 0.86 (0.58-1.29) 1.03 (0.65-1.61)
Transverse 1.01 (0.76-1.36) 0.95 (0.71-1.28) 0.92 (0.68-1.24) 1.02 (0.76-1.38) 0.96 (0.70-1.33) 1.00 (0.69-1.46)
Intercalary 2.26 (0.69-7.34) 2.76 (0.88-8.70) 2.57 (0.80-8.20) 2.50 (0.74-8.40) 3.05 (0.88-10.56) 2.75 (0.68-11.08)
Preaxial* 0.80 (0.50-1.28) 0.83 (0.52-1.32) 0.90 (0.57-1.42) 0.83 (0.52-1.34) 0.76 (0.45-1.28) 0.77 (0.43-1.40)
* Subcategory of longitudinal limb deficiency.
** Logistic regression models adjusted for energy intake, maternal race/ethnicity, maternal education, dietary folate intake, dietary fat intake, and study center.
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dren with orofacial defects are reported in Table 4 and
the results of the logistic regression models are reported
in Table 5. In the unadjusted logistic regression models,
statistically significant relationships were identified be-
tween the second quartile of nitrite intake and cleft pal-
ate (uOR = 0.82, 0.67-0.99), between the second quartile
of nitrosamine intake and cleft lip without cleft palate
(uOR = 0.74, 0.58-0.94), between the third quartile of ni-
trosamine intake and cleft lip without cleft palate (uOR
= 0.72, 0.56-0.92), between the second quartile of nitro-
samine intake and cleft lip with or without cleft palate
(uOR = 0.83, 0.72-0.97), between the third quartile of ni-
trosamine intake and cleft lip with or without cleft palate
(uOR = 0.82, 0.71-0.96) and between the fourth quartile
of nitrosamine intake and cleft palate (uOR = 0.77, 0.64-0.94). However, none of these relationships was statisti-
cally significant after adjustment for covariates. For the
adjusted logistic regression models, a significant relation-
ship was identified between the second quartile of nitrosa-
mine intake and cleft palate (aOR = 0.78, 0.64-0.95).
The descriptive statistics for diet for mothers of chil-
dren with limb malformations are reported in Table 6
and the results of the logistic regression models are
reported in Table 7. In the unadjusted logistic regression
models with the lowest quartile of intake serving as the
referent category, a significant relationship was noted for
the second quartile of total nitrite consumption and
longitudinal limb deficiency (uOR = 0.67, 0.46-0.98), but
this result was not significant after adjustment for cova-
riates. In the adjusted logistic regression models, there
was a significant relationship between the fourth quartile
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ciency (aOR = 4.70, 1.23-17.93).
Discussion
This study explored the relationship between maternal
consumption of dietary nitrates, total nitrites, nitrites (from
both animal and plant sources) and nitrosamines and
specific NTDs, orofacial clefts and limb malformations in
their offspring. The primary strength of the study is its
large and very well-characterized sample. It is the largest
study to date to investigate the relation between estimated
maternal intake of dietary nitrate, nitrite, and nitrosamines
and neural tube defects and examines several other types
of birth defects in relation to these exposures that have not
been examined before. Overall, estimated dietary intake of
these compounds did not appear to be significant risk fac-
tors for neural tube, oral cleft, or limb deficiency defects.
Croen et al. [1] also found no compelling associations
between maternal dietary intake of nitrates, nitrites, and
nitrosamines and neural tube defects in a California
study population, with most odds ratios for neural tube
defects slightly below 1.00 in the second, third, and
fourth quartiles compared with the first quartile of in-
take. Using tertiles instead of quartiles of intake, Brender
et al. [2] noted odds ratios of 0.8 and 0.9 for the upper
two tertiles of dietary nitrite and for total nitrite, 0.9 and
0.8. Neither study reported findings of the relation be-
tween dietary intake of these compounds and neural
tube defects by specific phenotype.
Of interest to this study, three studies found dietary ni-
trite and total nitrite to modify the association between
nitrosatable drug use and birth defects in offspring. In a
study of Mexican American women who resided in Texas
counties bordering Mexico, nitrosatable drug use was as-
sociated with these defects in the upper two tertiles of
nitrite and total nitrite intake, but not in the lowest tertile
of intake [2]. These findings were corroborated in the
National Birth Defects Prevention Study population [3] in
which the strongest associations between secondary/ter-
tiary amine drug exposure and anencephaly and spina
bifida were noted in the upper two tertiles of dietary
nitrite and total nitrite intake. Associations for cleft palate
and several types of heart defects were also stronger in
offspring of NBDPS participants who had the highest
estimated total nitrite intake [15]. These findings are con-
sistent with results of an experimental study with mice ex-
posed to ethylenethiourea (a nitrosatable compound) and
nitrite [26]. Malformations were observed when these
compounds were administered together, but not separ-
ately. With the dose of the nitrosatable compound held
constant, the percentage of malformations increased as
the dose of nitrite increased, indicating that the combined
effects of these compounds might be due to the
nitrosation products formed within the stomach.One possible limitation of our study is the potential
for measurement error in the self-reported food fre-
quency questionnaire. Because data from food frequency
questionnaires are known to be measured with error
[19,20], logistic regression models were estimated using
the SIMEX algorithm. Since there was no “gold stand-
ard” available to quantify the amount of measurement
error in the data, extra error was considered by adding
0% to 60% additional variance in increments of 10%.
There was no evidence that even the highest levels of
measurement error made any substantive different in
the results so maximum likelihood estimation was used
for all subsequent modeling. It is possible that the inabil-
ity to explicitly quantify the degree of measurement
error in the exposure variables could bias the results to-
wards the null. However, any bias due to measurement
error should be non-differential because the mothers
were not aware of the nitrate, nitrite and nitrosamine
content in the foods they consumed when they com-
pleted the dietary recall questionnaire.
In this study, we focused on dietary contributions to
daily intake of nitrate, nitrite, and nitrosamines, although
drinking water is another potential source of nitrate in-
take. On the other hand, the World Health Organization
noted, in a recent review, that the contribution of drink-
ing water to nitrate intake is usually less than 14% [27].
Conclusion
Over 165 unadjusted and 165 adjusted logistic regression
models were fit in the course of this analysis, and only
four adjusted odds ratios had confidence intervals that did
not include the null value. Though no explicit adjustment
for multiple comparisons was made, it is likely that the
four significant results would not remain so if adjusted.
Given the small number of significant results relative to
the number of models considered and the modest effects
for the non-significant results, it seems reasonable to con-
clude that there is insufficient evidence to suggest any re-
lationship between dietary intake of nitrates, nitrosamines,
total nitrites or nitrates from animal or plant sources and
any of the three groups of birth defects including NTDs,
orofacial clefts and limb malformations. Because nitrite
can react with nitrosatable compounds within the stom-
ach to form N-nitroso compounds, further studies are
recommended on the relation between the interaction of
dietary nitrites with nitrosatable drugs and adverse preg-
nancy outcomes.
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